Veeva (VEEV) is down -9.8%, or -$26.57 to $243.94.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Morning Movers: AnaptysBio sinks after GSK sues
- Veeva price target raised to $319 from $314 at Baird
- Veeva price target lowered to $280 from $310 at UBS
- Veeva price target lowered to $280 from $300 at Canaccord
- Strong Financial Performance and Growth Prospects Make Veeva Systems a Compelling Investment Opportunity